Leo Pavliv - 31 May 2022 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Signature
Leo Pavliv by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
31 May 2022
Net transactions value
-$70,015
Form type
4
Filing time
01 Jul 2022, 15:13:03 UTC
Previous filing
29 Apr 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Other $70,015 -33,500 -21% $2.09 129,618 31 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPIX Options (right to buy) Disposed to Issuer $0 -5,000 -100% $0.000000* 0 17 Mar 2021 Common Stock 5,000 $3.22 Direct F1
transaction CPIX Options (right to buy) Disposed to Issuer $0 -5,000 -100% $0.000000* 0 16 Mar 2022 Common Stock 5,000 $2.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Leo Pavliv is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Retired from position as Executive Vice President, Chief Development & Operations Officer on May 31, 2022. All unvested equity awards forfeited upon retirement.